CARTANA In Situ Sequencing (ISS) chosen as key enabling technology in European Horizon 2020 funded projects linked to international Human Cell Atlas initiative
Stockholm, January 23, 2019. The European Union’s Horizon 2020 funding program has confirmed support for six pilot European Human Cell Atlas projects designed to contribute to the international Human Cell Atlas initiative (HCA) with studies of the brain, uterus, lung, pancreas and human gonad development. In parallel, Swedish biotechnology company CARTANA today announced that it is to become a full partner three out of the six funded HCA projects, whereby its In Situ Sequencing (ISS) technology will be applied to spatially map cell types in the different tissue samples. ISS enables single